MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019)
MeiraGTx Holdings' (MGTX) quarterly Tax Provisions came in at $3.5 million in Q4 2019, up 837.59% YoY from $373197.3 in Q4 2018, and up 1133.18% on a QoQ basis from -$338670.0 in Q3 2019.
MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019) Analysis & Trends
MeiraGTx Holdings (MGTX) has 2 years of Tax Provisions data on file, last reported at $3.5 million in Q4 2019.
- Quarterly Tax Provisions rose 837.59% year-over-year to $3.5 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.6 million (changed N/A YoY) and the FY2019 annual result came in at $3.1 million, up 746.93% from the prior year.
- Tax Provisions advanced to $3.5 million in Q4 2019, from -$338670.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $3.5 million in Q4 2019 to a low of -$474391.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.50 Mn |
| Sep 30, 2019 | -338,670.00 |
| Jun 30, 2019 | -91,390.00 |
| Dec 31, 2018 | -474,391.00 |